Drugmakers plan to raise U.S. prices on at least 350 branded medications including vaccines against COVID, RSV and shingles and blockbuster cancer treatment Ibrance, even as the Trump administration pressures them for cuts, according to data provided exclusively by healthcare research firm 3 Axis Advisors.
The number of price increases for 2026 is up from the same point last year, when drugmakers unveiled plans for raises on more than 250 drugs. The median of this year’s price hikes is around 4% - in line with 2025.
U.S. patients currently pay by far the most for prescription medicines, often nearly 3 times more than in other developed nations, and Trump has been pressuring drugmakers to lower their prices to what patients pay in similarly wealthy nations.
“Pressuring” how? Any institution with teeth Trump has already neutered.
He was talking about TrumpRx.com, and how we were going to pay prices that EU pays, etc.
That doesn’t sound like pressure. Just more self-aggrandizement.
Does that mean they will only come down by 1000%?
He’ll quieten down once he receives Peace Prize from them.
